Neumora Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 7.84 M | $83.09 M | 1.15% | 4.92% |
BLACKROCK, INC. | 02/07/2025 | 7.11 M | $75.33 M | 14.87% | 4.46% |
SOFTBANK GROUP CORP. | 02/14/2025 | 6.54 M | $69.34 M | -13.33% | 4.10% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 5.00 M | $53.03 M | -4.31% | 3.14% |
VANGUARD GROUP INC | 02/11/2025 | 4.57 M | $48.47 M | 4.46% | 2.87% |
MIC CAPITAL MANAGEMENT UK LLP | 02/14/2025 | 4.46 M | $47.28 M | 0.00% | 2.80% |
SIREN, L.L.C. | 02/14/2025 | 4.40 M | $46.60 M | 68.65% | 2.76% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 4.00 M | $42.40 M | 604.94% | 2.51% |
CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 3.70 M | $39.22 M | 692.06% | 2.32% |
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST | 01/13/2025 | 3.31 M | $35.08 M | 0.00% | 2.08% |
ICONIQ CAPITAL, LLC | 02/14/2025 | 2.56 M | $27.13 M | -24.70% | 1.61% |
LUNATE HOLDING RSC LTD | 02/14/2025 | 2.12 M | $22.52 M | 100.00% | 1.33% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 2.07 M | $21.96 M | 0.00% | 1.30% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.97 M | $20.89 M | -0.48% | 1.24% |
JOHNSON & JOHNSON | 02/13/2025 | 1.85 M | $19.60 M | 0.00% | 1.16% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 1.52 M | $16.10 M | 653.17% | 0.95% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.50 M | $15.90 M | 100.00% | 0.94% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.19 M | $12.61 M | 559.17% | 0.75% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 1.03 M | $10.97 M | 0.00% | 0.65% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 955,106 | $10.12 M | 15.34% | 0.60% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 900,000 | $9.54 M | 125.00% | 0.56% |
ORBIMED ADVISORS LLC | 02/14/2025 | 804,996 | $8.53 M | -46.33% | 0.51% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 793,800 | $8.41 M | 7,606.80% | 0.50% |
NORTHERN TRUST CORP | 02/14/2025 | 734,847 | $7.79 M | 7.69% | 0.46% |
MORGAN STANLEY | 02/14/2025 | 731,412 | $7.75 M | 106.79% | 0.46% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 704,154 | $7.46 M | 0.84% | 0.44% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 640,923 | $6.79 M | 88.50% | 0.40% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 636,300 | $6.74 M | 100.00% | 0.40% |
CALLAN CAPITAL, LLC | 02/03/2025 | 636,194 | $6.74 M | -3.78% | 0.40% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 633,300 | $6.71 M | 100.00% | 0.40% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 625,000 | $6.63 M | 100.00% | 0.39% |
LMR PARTNERS LLP | 02/14/2025 | 616,400 | $6.53 M | 507.29% | 0.39% |
CANDRIAM S.C.A. | 02/07/2025 | 571,027 | $6.05 M | -15.56% | 0.36% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 521,013 | $5.52 M | 273.92% | 0.33% |
AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 475,000 | $5.04 M | 100.00% | 0.30% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 437,800 | $4.64 M | 1,086.45% | 0.27% |
STEMPOINT CAPITAL LP | 02/14/2025 | 428,137 | $4.54 M | 100.00% | 0.27% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 350,000 | $3.71 M | -12.50% | 0.22% |
WOODLINE PARTNERS LP | 02/14/2025 | 310,454 | $3.29 M | 0.94% | 0.19% |
CITADEL ADVISORS LLC | 02/14/2025 | 295,400 | $3.13 M | 300.27% | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 289,300 | $3.07 M | 147.27% | 0.18% |
NOMURA HOLDINGS INC | 02/14/2025 | 281,400 | $2.98 M | 100.00% | 0.18% |
SOROS CAPITAL MANAGEMENT LLC | 02/14/2025 | 279,333 | $2.96 M | -45.11% | 0.18% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 257,430 | $2.73 M | 100.00% | 0.16% |
WEXFORD CAPITAL LP | 02/14/2025 | 252,122 | $2.67 M | 15.72% | 0.16% |
CERITY PARTNERS LLC | 02/13/2025 | 243,908 | $2.59 M | 0.42% | 0.15% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 220,970 | $2.34 M | -2.11% | 0.14% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 199,947 | $2.12 M | -10.29% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 166,822 | $1.77 M | 29.11% | 0.10% |
ADDIS & HILL, INC | 01/31/2025 | 163,386 | $1.73 M | -45.54% | 0.10% |
Neumora Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 112 institutional investors and hedge funds held shares of Neumora Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
Versant Capital Management, Inc: 0
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
Ronald Blue Trust, Inc.: 0
GAMMA Investing LLC: 0
FMR LLC: 7.84 M
BlackRock, Inc.: 7.11 M
49.08% of Neumora Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 79.00 M shares in the last 24 months. This purchase volume represents approximately $56.88 M in transactions.